MUMBAI, India, Feb. 13 -- Intellectual Property India has published a patent application (202641009435 A) filed by National Institute Of Technology, Warangal, Telangana, on Jan. 29, for 'a bio-implantable device and a method of manufacturing thereof.'
Inventor(s) include P Subhash Chandra Bose; Rawad Yaqoub Aljabr; and Sonawane Shirish Hari.
The application for the patent was published on Feb. 13, under issue no. 07/2026.
According to the abstract released by the Intellectual Property India: "The present disclosure discloses a bio-implantable device (108). The bio-implantable device includes a composite core, formed by magnesium (Mg) base matrix having niobium reinforcement. The composite core includes composition in weight % of magnesium (Mg) based material ranging from 78% to 93%, niobium (Nb) particles ranging from 5% to 20%, and the balance being hydroxyapatite (HAP) with inevitable impurities. The bio-implantable device 15 (108) further includes at least a portion of the hydroxyapatite (HAP) binds niobium reinforcement and magnesium (Mg) base matrix. Further, the bio-implantable device (108) includes an in-situ protective layer formed on the composite core, wherein the in-situ protective layer formed by a portion of the hydroxyapatite (HAP) from the composition of the composite core, to encapsulate bound niobium reinforced magnesium composite. The bio-implantable device (108) exhibits a 20 compressive strength (UCS) ranging between 250 - 320 MPa with a fracture strain ranging from 5.5% to 7.5%."
Disclaimer: Curated by HT Syndication.
